Flores-Ocampo Victor, Lim Amanda Wei-Yin, Ogonowski Natalia S, García-Marín Luis M, Ong Jue-Sheng, Yeow Dennis, Gonzaga-Jauregui Claudia, Kumar Kishore R, Rentería Miguel E
Brain & Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
School of Biomedical Sciences, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Genes (Basel). 2025 Apr 15;16(4):454. doi: 10.3390/genes16040454.
Parkinson's disease (PD) is a genetically complex neurodegenerative disorder. Up to 15% of cases are considered monogenic. However, research on monogenic PD has largely focused on populations of European ancestry, leaving gaps in our understanding of genetic variability in other populations. This study addresses this gap by analysing the allele frequencies of pathogenic and likely pathogenic variants in known monogenic PD genes across eight global populations, using data from the gnomAD database.
We compiled a list of 27 genes associated with Mendelian PD from the Online Mendelian Inheritance in Man (OMIM) database, and identified pathogenic and likely pathogenic variants using ClinVar. We then performed pairwise comparisons of allele frequencies across populations included in the gnomAD database. Variants with significant frequency differences were further assessed using in silico pathogenicity predictions.
We identified 81 variants across 17 genes with statistically significant allele frequency differences between at least two populations. Variants in were the most prevalent among monogenic PD-related genes, followed by , , , and . exhibited the greatest variability in allele frequencies, particularly the NM_000157.4:c.1226A>G (p.Asn409Ser) variant. Additionally, we observed significant population-specific differences in PD-related variants, such as the NM_032409.3:c.1040T>C (p.Leu347Pro) variant in , which was most prevalent in East Asian populations.
Our findings reveal substantial population-specific differences in the allele frequencies of pathogenic variants linked to monogenic PD, emphasising the need for broader genetic studies beyond European populations. These insights have important implications for PD research, genetic screening, and understanding the pathogenesis of PD in diverse populations.
帕金森病(PD)是一种具有遗传复杂性的神经退行性疾病。高达15%的病例被认为是单基因的。然而,对单基因帕金森病的研究主要集中在欧洲血统人群,这使得我们对其他人群的遗传变异性了解不足。本研究通过使用gnomAD数据库的数据,分析八个全球人群中已知单基因帕金森病基因的致病和可能致病变异的等位基因频率,填补了这一空白。
我们从《人类孟德尔遗传在线》(OMIM)数据库中编制了一份与孟德尔帕金森病相关的27个基因的列表,并使用ClinVar鉴定致病和可能致病的变异。然后,我们对gnomAD数据库中纳入的人群的等位基因频率进行了两两比较。使用计算机致病性预测进一步评估具有显著频率差异的变异。
我们在17个基因中鉴定出81个变异,至少两个群体之间的等位基因频率存在统计学显著差异。 中的变异在单基因帕金森病相关基因中最为普遍,其次是 、 、 和 。 等位基因频率的变异性最大,特别是NM_000157.4:c.1226A>G(p.Asn409Ser)变异。此外,我们观察到帕金森病相关变异存在显著的群体特异性差异,例如 中的NM_032409.3:c.1040T>C(p.Leu347Pro)变异,在东亚人群中最为普遍。
我们的研究结果揭示了与单基因帕金森病相关的致病变异等位基因频率存在显著的群体特异性差异,强调了除欧洲人群之外进行更广泛遗传研究的必要性。这些见解对帕金森病研究、基因筛查以及理解不同人群中帕金森病的发病机制具有重要意义。